Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 2
2006 2
2007 1
2008 1
2009 2
2011 1
2012 2
2013 4
2014 7
2015 16
2016 8
2017 8
2018 5
2019 13
2020 14
2021 25
2022 17
2023 17
2024 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
Albuminuria and cardiorenal risk.
Georgianos PI, Dounousi E, Liakopoulos V. Georgianos PI, et al. Among authors: dounousi e. Curr Opin Cardiol. 2023 Jul 1;38(4):331-336. doi: 10.1097/HCO.0000000000001055. Epub 2023 Mar 28. Curr Opin Cardiol. 2023. PMID: 37016948 Review.
Redox Systems Biology in Chronic Kidney Disease.
Roumeliotis S, Liakopoulos V, Veljkovic A, Dounousi E. Roumeliotis S, et al. Among authors: dounousi e. Oxid Med Cell Longev. 2023 May 3;2023:9864037. doi: 10.1155/2023/9864037. eCollection 2023. Oxid Med Cell Longev. 2023. PMID: 37180759 Free PMC article. No abstract available.
Editorial: Molecular Mechanisms in Chronic Kidney Disease.
Torino C, Dounousi E, Abd ElHafeez S, Prohic N. Torino C, et al. Among authors: dounousi e. Front Cell Dev Biol. 2021 Jun 29;9:712834. doi: 10.3389/fcell.2021.712834. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34268317 Free PMC article. No abstract available.
Biomarkers of vascular calcification in serum.
Roumeliotis S, Roumeliotis A, Dounousi E, Eleftheriadis T, Liakopoulos V. Roumeliotis S, et al. Among authors: dounousi e. Adv Clin Chem. 2020;98:91-147. doi: 10.1016/bs.acc.2020.02.004. Epub 2020 Apr 27. Adv Clin Chem. 2020. PMID: 32564789 Review.
PCSK9 in chronic kidney disease.
Pavlakou P, Liberopoulos E, Dounousi E, Elisaf M. Pavlakou P, et al. Among authors: dounousi e. Int Urol Nephrol. 2017 Jun;49(6):1015-1024. doi: 10.1007/s11255-017-1505-2. Epub 2017 Jan 13. Int Urol Nephrol. 2017. PMID: 28084558 Review.
Intraocular pressure changes during hemodialysis.
Liakopoulos V, Demirtzi P, Mikropoulos DG, Leivaditis K, Dounousi E, Konstas AG. Liakopoulos V, et al. Among authors: dounousi e. Int Urol Nephrol. 2015 Oct;47(10):1685-90. doi: 10.1007/s11255-015-1043-8. Epub 2015 Jul 4. Int Urol Nephrol. 2015. PMID: 26141848 Review.
140 results